Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Withdrawn 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Hemangioma 9Hemangioma, Capillary 7Melanoma 6Breast Neoplasms 5Carcinoma, Hepatocellular 4Sarcoma 3Prostatic Neoplasms 3Pancreatic Neoplasms 3Multiple Myeloma 3Hypertension, Portal 3Hemangiosarcoma 3Fallopian Tube Neoplasms 3Urinary Bladder Neoplasms 2Sarcoma, Kaposi 2Ovarian Neoplasms 2Hemangioma, Cavernous, Central Nervous System 2Colorectal Neoplasms 2Carcinoma, Ovarian Epithelial 2Carcinoma, Non-Small-Cell Lung 2von Hippel-Lindau Disease 1Uterine Cervical Neoplasms 1Urethral Neoplasms 1Ureteral Neoplasms 1Ulcer 1Tuberous Sclerosis 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Spinal Cord Neoplasms 1Smoldering Multiple Myeloma 1Skin Neoplasms 1

Interventions

epigallocatechin gallate 1Vitamin B 12 1Sugars 1Radiotherapy, Intensity-Modulated 1Propranolol 1Papanicolaou Test 1Narrow Band Imaging 1Microsurgery 1Maltose 1Lasers, Gas 1Lasers, Dye 1Laser Therapy 1Interferon-alpha 1Hyaluronic Acid 1Human Papillomavirus DNA Tests 1Folic Acid 1Colposcopy 1Cisplatin 1Cidofovir 1Celecoxib 1Carboplatin 1Bevacizumab 13,3'-diindolylmethane 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Papilloma × Propranolol × Clear all
NCT01058317 2013-11-21

Propranolol Administration in Pediatric Patients With Recurrent Respiratory Papillomatosis

Massachusetts Eye and Ear Infirmary

Phase 2/3 Withdrawn

Recurrent respiratory papillomatosis, Papilloma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡